$253 Million is the total value of Endurant Capital Management LP's 70 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 59.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CI | Sell | CIGNA CORP NEW | $10,774,000 | -20.0% | 66,997 | -5.6% | 4.26% | -40.2% |
| ZBH | Sell | ZIMMER BIOMET HLDGS INC | $9,869,000 | -23.2% | 77,286 | -37.6% | 3.90% | -42.6% |
| WMGI | Sell | WRIGHT MED GROUP N V | $7,781,000 | +1.3% | 247,417 | -12.3% | 3.08% | -24.2% |
| RCM | Sell | R1 RCM INC | $7,256,000 | +2.2% | 750,376 | -16.0% | 2.87% | -23.6% |
| MDT | Sell | MEDTRONIC PLC | $3,241,000 | -61.6% | 35,579 | -61.7% | 1.28% | -71.3% |
| AGN | Sell | ALLERGAN PLC | $2,674,000 | -83.2% | 18,263 | -84.7% | 1.06% | -87.4% |
| BHC | Sell | BAUSCH HEALTH COS INC | $2,577,000 | -14.9% | 104,344 | -36.3% | 1.02% | -36.3% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $1,768,000 | -70.0% | 102,593 | -77.8% | 0.70% | -77.6% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $1,712,000 | -27.4% | 14,364 | -33.5% | 0.68% | -45.7% |
| XRAY | Sell | DENTSPLY SIRONA INC | $1,438,000 | -67.4% | 28,988 | -75.5% | 0.57% | -75.6% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $744,000 | +26.1% | 52,268 | -75.0% | 0.29% | -5.8% |
| CVS | Sell | CVS HEALTH CORP | $595,000 | -93.8% | 11,036 | -92.5% | 0.24% | -95.4% |
| ANAB | Sell | ANAPTYSBIO INC | $444,000 | -45.3% | 6,082 | -52.2% | 0.18% | -59.0% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $401,000 | -72.5% | 16,447 | -83.9% | 0.16% | -79.4% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $213,000 | -61.5% | 23,576 | -64.6% | 0.08% | -71.2% |
| MCK | Exit | MCKESSON CORP | $0 | – | -4,966 | -100.0% | -0.29% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -58,240 | -100.0% | -0.30% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -39,961 | -100.0% | -0.43% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -6,588 | -100.0% | -0.45% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -30,560 | -100.0% | -0.57% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $0 | – | -73,884 | -100.0% | -0.60% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -7,319 | -100.0% | -0.61% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -455,018 | -100.0% | -0.82% | – |
| PETS | Exit | PETMED EXPRESS INC | $0 | – | -67,010 | -100.0% | -0.82% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -236,648 | -100.0% | -1.08% | – |
| MYL | Exit | MYLAN N V | $0 | – | -77,135 | -100.0% | -1.12% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -54,977 | -100.0% | -1.13% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -318,185 | -100.0% | -1.49% | – |
| PODD | Exit | INSULET CORP | $0 | – | -40,727 | -100.0% | -1.71% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -81,401 | -100.0% | -1.87% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -16,732 | -100.0% | -2.20% | – |
| EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -85,272 | -100.0% | -2.78% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -135,805 | -100.0% | -2.95% | – |
| MDRX | Exit | ALLSCRIPTS HEALTHCARE SOLUTN | $0 | – | -591,533 | -100.0% | -3.01% | – |
| DVA | Exit | DAVITA INC | $0 | – | -140,729 | -100.0% | -3.83% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -46,100 | -100.0% | -4.24% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -168,609 | -100.0% | -5.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.